SRSheila C Rocha-Brischiliari

Sheila C Rocha-Brischiliari

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Sheila C Rocha-Brischiliari has a total of 15 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Risk factors for cervical HPV infection and genotypes distribution in HIV-infected South Brazilian women

    by Sheila C Rocha-Brischiliari, Fabrícia Gimenes, André L P de Abreu, Mary M T Irie, Raquel P Souza, Rosangela G Santana, Angela A F Gravena, Maria D de B Carvalho, Marcia E L Consolaro, Sandra M Pelloso

    Background: Human Papillomavirus (HPV) infection is particularly burdensome for women infected with human immunodeficiency virus (HIV), which increases their risk of developing cervical lesions and cancer (CC). We conducted a molecular study of the distribution of cervical HPV genotypes and the risk factors for this infection in HIV-infected Brazilian women. Findings: Cervical and endocervical samples for Papanicolaou screening and HPV detection were collected from 178 HIV-infected women using highly active antiretroviral therapy (HAART) of Maringá city/Brazil. Risk factors were assessed using a standardized questionnaire, and the data regarding to HIV infection from medical records. HPV was detected by polymerase chain reaction (PCR), and genotyping using PCR-restriction fragment length polymorphism analysis. HIV infection was well controlled, but women with a current CD4+ T lymphocyte count between 200–350 cells/mm3 (37.6%) had a two-fold greater risk of HPV infection than those with > 350 cells/mm3 (26.4%). HPV was associated with parity ≥3, hormonal contraceptive use and current smoker. HPV infection occurred with high frequency (46.6%) but a low frequency of cervical abnormalities was detected (7.30%), mainly low-grade squamous intraephitelial cervical lesions (LSIL) (84.6%). A high frequency of multiple HPV infections was detected (23.0%), and the most frequent HPV genotype was HPV-72 (6.7%), followed by −16, -31 and -51 (6.14% each). Conclusions: We showed that HAART use does not protect HIV-infected women from HPV, but appear to exert some protection against cervical lesions development. This study provides other important information about risk factors and cervical HPV in HIV-infected women, which can contribute to planning protocols.


  • Open Access

    Differences in the mutation of the p53 gene in exons 6 and 7 in cervical samples from HIV- and HPV-infected women

    by Raquel P Souza, Fabrícia Gimenes, André Lp de Abreu, Sheila C Rocha-Brischiliari, Maria Db de Carvalho, Érika C Ferreira, Marcelo G Bonini, Sandra M Pelloso, Marcia EL Consolaro

    Background: Human Papillomavirus (HPV) infection is a serious problem for human immunodeficiency virus (HIV)-infected women, increases their risk of cervical lesions and cancer. In cervical carcinogenesis, mutations in the p53 gene occur most frequently within exons 5–8. To our knowledge, no previous studies have analyzed mutations in exons 5–8 of the p53 gene in HIV- and HPV-infected women. In our study, we verified these mutations in women with and without cervical abnormalities. Findings: The study included 160 women, divided into three groups: (1) 83 HPV- and HIV-infected women (HIV group); (2) 37 HPV-infected/HIV-uninfected (control group); and (3) 40 normal cytology/DNA-HPV negative/HIV-uninfected women (negative control p53 reactions). HPV-DNA was detected using polymerase chain reaction (PCR) and genotyping by PCR-restriction fragment length polymorphism analysis. Using primers for exons 5–8, the mutation of the p53 gene was verified by PCR-single strand conformational polymorphism. The total mutation of the p53 gene in exons 5–8 was not significantly associated with the HIV and control groups. The mutations in exon 7 were the highest in the HIV group (43.8%) and in exon 6 in the control group (57.2%) (p = 0.0793) suggesting a tendency toward differential mutation in exon 7 in the HIV group. Conclusions: Our study provides preliminary evidence that the mutation in exon 7 might be an important differentiating factor for cervical carcinogenesis in HIV-infected women. This aspect deserves an additional cross-sectional and longitudinal study using a larger sample size with a higher number of High-grade squamous intraephitelial lesion (HSIL) to observe the evolution of cervical lesions.


  • Open Access

    O cotidiano do indivíduo com ferida crônica e sua saúde mental

    by Maria Angélica Pagliarini Waidman, Sheila Cristina Rocha, Juliana Landi Correa, Adriano Brischiliari, Sonia Silva Marcon

    O objetivo deste estudo foi identificar como está a saúde mental das pessoas acometidas por ferida crônica. Pesquisa descritiva de abordagem qualitativa, realizada no período de agosto de 2008 a março de 2009, a qual utilizou a entrevista como técnica para a coleta de dados. Participaram seis portadores de feridas crônicas em acompanhamento pelo Ambulatório de Especialidades de um Hospital Público. Para análise dos dados utilizou-se a técnica de análise de conteúdo. Os resultados demonstram que há perda da autoestima, dor, déficit na qualidade do sono, inaptidão para o trabalho, vergonha e constrangimento para se relacionar socialmente, levando à propensão de problemas de ordem emocional. Concluímos que o portador de feridas crônicas apresenta propensão a desenvolver problemas que colocam em risco sua saúde mental.